Dr Reddys Laboratories
BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
News on Dr Reddys Laboratories
Dr Reddy's launches open offer for OctoPlus shares
10.53 am | 14 Dec 2012 | Source: Moneycontrol.com
Dr Reddy's Laboratories has launched the recommended public offer to acquire all the outstanding shares of OctoPlus NV at 0.52 euro a share, the pharm...
Credit Suisse upgrades Dr Reddy's on US outlook
1.00 pm | 13 Dec 2012 | Source: Reuters
Credit Suisse upgrades Dr. Reddy's Laboratories to 'outperform' from 'neutral' and raises its target price to Rs 2,150 from Rs 1,900, citing expectati...
Go long in Dr Reddys Lab on dips: Amit Gupta
10.15 am | 10 Dec 2012 | Source: CNBC-TV18
Go long in Dr Reddys Laboratories on dips and look for a target of Rs 1,920 and keep stop loss below Rs 1750, says Amit Gupta, ICICI Direct....
Dr Reddys launches generic Revatio tablets in US
2.13 pm | 19 Nov 2012 | Source: Moneycontrol.com
Dr Reddys has launched Sildenafil Tablets (20mg), a bioequivalent version of REVATIO (Sildenafil) tablets in the US market on November 16, 2012....
Quick Links for Dr Reddys Laboratories
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.